Seeking Alpha

Rod Raynovich's  Instablog

Rod Raynovich
Send Message
Rod Raynovich is an entrepreneur and executive with a focus on life science companies and medical technology trends.He has over 35 years executive experience including Abbott and JNJ and has been involved three successful start-ups. Before starting Raygent and other companies he was also a... More
My company:
Raygent Capital
My blog:
Raygent.com,Rayno Life Science
  • Clinical Diagnostic Companies:Financial Metrics 2014 Q1Results-Best Picks 0 comments
    Jun 5, 2014 8:56 AM | about stocks: EXAS, HOLX, NEOG, NSTG

    Potential upside in EXAS, NSTG and NEOG: all are current Rayno Dx and Tools picks.

    A Few Clinical Diagnostic Stocks Were Hit By A Revenue Miss

    • With "momentum trading" days over for now, revenue growth is the focus.
    • Companies with disappointing Q1 revenues: Abaxis (NASDAQ:ABAX), Alere (NYSE:ALR), Response Genetics (NASDAQ:RGDX) and Quidel (NASDAQ:QDEL). Q2 recovery will be key.
    • Many of these stocks are losers YTD after a great year in 2013; stocks peaked in Feb/March.
    • Rayno Dx and Tools winners YTD: Illumina (NASDAQ:ILMN), Sequenom (NASDAQ:SQNM), Hologic (NASDAQ:HOLX), Exact Sciences (NASDAQ:EXAS) and ThermoFisher (NYSE:TMO).
    • GenProbe acquisition by Hologic (HOLX) is gold standard for valuation at P/S of 5.
    • Look for traction with ExactSci (EXAS), NanoString Tech (NASDAQ:NSTG) and Neogen (NASDAQ:NEOG) with upgrade support from bankers.
    • Illumina (ILMN) and Pacific Bio (NASDAQ:PACB) are sequencing plays but are not in analysis below.

    Clinical Diagnostics and Tools Stocks

    CompanyTickerPriceRevRevQ4RevPrice2014P/SPEPEGP/BMarket 
      My'1120122013201331-MayRevEst    Cap 
    GenProbe*GPRO80642143$-000-sold 665765641.9700$B 
                  
    AbaxisABAX2817940.8176.4411984.7672.34.80.937 
    AlereALR362,7107723,03035.83,0401.2n/an/a23.58 
    CepheidCPHD31331113.3401.345459.76.8n/an/a8.83.14 
    ExactSciEXAS 4.1514.113.4811.6328n/an/a7.41.12 
    GenMark DxGNMK    112516n/an/a4.40.458 
    GenomHlthGHDX2623668.8259.2262822.9n/an/a5.80.812 
    HologicHOLX 2,160612.42,49024.42,4802.4n/an/a3.46.75 
    Immucor**BLUD2034583.3 sold 27n/a5.5212.2n/an/a 
    LuminexLMNX2020355.2213.4172313.4461.22.50.722 
    MeridianVIVO2317944.8188.720.4193.64.2231.95.40.846 
    NanostringTNSTGNew 10.1$31.5014.947.96.3n/an/a70.269 
    NanosphereNSPH  3.4101.35199.4n/an/a30.136 
    NeogenNEOG4119459.622537.8245.76.9502.74.81.39 
    OrasureOSUR 89.428.898.96.32103.63.5n/an/a2.3352.9 
    QiagenQGEN201,2503631,310231,3703.9799.425.35 
    QuidelQDEL1515650.2175.422.7175.7554n/a3.4776.8 
    Resp GenetRGDX218.1   22.22n/an/a160.04 
    SequenomSQNM 71.545.1162.43.072141.3n/an/an/a0.357 
    SeraCare#SRLS3.746.211 sold 443.51.836n/a40n/a 
    TechneTECH813128433087.83579.4292.343,250 
    ThermoFish.TMO  347013,090116.9172.7152.42.346,640 
    TrinityBioTRIBNew   241104.9592.930.54 
                  
    ** sold for $1.97B to TBG Capital#sold for $80M        
    * sold for$3.7B to HologicNames in BOLD are on focus list     
                  
                  
                  

    Disclosure: I am long HOLX, PACB, TRIB.

    Stocks: EXAS, HOLX, NEOG, NSTG
Back To Rod Raynovich's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »

Latest Comments


Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.